For any clinical trial it is important to undertake a robust and realistic assessment of feasibility to determine if the study is a viable prospect. The feasibility study will be coordinated by the CI/PI/study team and the final decision rests with the relevant ICHT Clinical Division research manager.
To assess whether the study is deemed feasible, it is advisable to consider a range of criteria, with the help of other teams around the College and Trust, including evaluations of patient recruitment targets, inclusion/exclusion criteria, equipment and resources, facilities and locations.
Support at this early stage in the process from all the identified contributors will give the study the best possible chance to be completed successfully within budget, on time and generating high quality data.
|Type||Where to find|
|Key contacts||Clinical Divisions; Pharmacy; Imaging; Pathology; ICTU; Research facilities|
|Useful links||NIHR Clinical Trials Toolkit - feasibility
NIHR CRN - feasibility
|NIHR benchmark||Prior to NIHR 70-day benchmark|
|Process map links||This activity occurs in the feasibility stage:
> Imperial College London as sponsor
> Imperial College Hospital NHS Trust as sponsor
> Commercial organisation as sponsor
> Non-commercial organisation as sponsor